Presently, over 240 novel, patient friendly diabetes monitoring devices are available / being developed by more than 80 device developers, claims Roots Analysis

Author : kevin987
Publish Date : 2021-02-16 12:56:17


Presently, over 240 novel, patient friendly diabetes monitoring devices are available / being developed by more than 80 device developers, claims Roots Analysis

Over time, a number of companies have developed advanced variants of the conventional blood glucose monitoring devices, which are portable, and minimally / non-invasive. Many such next generation solutions have connectivity features that enable patients’ health data to be captured and shared with medical professionals, upon request. In addition, there are a number of innovative continuous glucose monitoring (CGM) systems, which are designed to provide real-time insights on blood glucose levels. Newer variants of these products have intuitive software that enables patients to quickly make important treatment-related decisions.

 

  • An overview of current market landscape of the diabetes monitoring devices, providing information on device specifications, such as type of device (self-monitoring blood glucose device and continuous blood glucose monitoring devices), current status of development (preclinical, clinical and marketed), target patient segment (children, adults and elderly patients), analyte procurement (invasive, non-invasive and minimally invasive), volume of analyte used (less than 0.8 µL, 0.8 to 2 µL and more than 2 µL), processing speed (fast and slow), wearability (wearable and non-wearable), wireless connectivity, water resistance potential, provision for alerts / alarms, device memory attributes and glucose measurement range. In addition, the report presents the details of the companies developing these devices, including information on type of developer (industry and non-industry), year of establishment, company size, location of headquarters and leading developers.
  • A detailed competitiveness analysis of diabetes monitoring devices, taking into consideration the supplier power (based on the experience / expertise of the developer) and product specifications (type of device, current status of development, target patient segment, analyte procurement, volume of analyte used, processing speed, wireless connectivity, water resistance potential, provision for alerts / alarms and device memory attributes).
  • An analysis of the partnerships that have been inked by the stakeholders in this domain, during the period between 2015 and 2020 (till August), covering product / technology integration agreements, commercialization agreements, distribution agreements, product development agreements, acquisitions, product development and commercialization agreements and other relevant types of deals.

 

To order this 180+ page report, which features 60+ figures and 80+ tables, please visit this link

 

The USD 34 billion (by 2030) financial opportunity within the diabetes monitoring devices market has been analyzed across the following segments:

  • Type of Device
  • Self-monitoring Blood Glucose Devices
  • Continuous Blood Glucose Monitoring Devices

 

  • Diabetes Type
  • Diabetes Type 1
  • Diabetes Type 2

 

  • Self-monitoring Blood Glucose Devices
  • Lancing Devices
  • Blood Glucose Meters
  • Testing Strips

 

  • Continuous Blood Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receivers

 

  • Key Geographical Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and North Africa
  • Rest of the World

 

The Diabetes Monitoring Devices Market, 2020-2030 report features the following companies, which we identified to be key players in this domain:

  • APExBIO
  • Ascensia Diabetes Care
  • i-SENS
  • Oak Tree Health
  • SD Biosensor
  • TaiDoc Technology
  • VivaChek Laboratories

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction
 

4. Current Market Landscape
 

5. Product Competitive Analysis
 

6. Partnerships and Collaborations
 

7. Company Profiles
 

8. Diabetes Monitoring Devices Related Initiatives of Big Pharma Players
 

9. Market Sizing and Opportunity Analysis
 

10. Concluding Remarks

 

11. Executive Insights

 

12. Appendix 1: Tabulated Data

 

13. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/diabetes-monitoring-devices-market.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]



Category : general

The Open Group OG0-091 Questions And Answers (2020)

The Open Group OG0-091 Questions And Answers (2020)

- 100% real and updated exam questions with answers for all famous certifications. Pass in first attempt .Error Free Products with 24/7 Customer Support.Special discount offer for all customer


nerous as a partner. I think someone is trying to make that look criminal when it is not.rgrregrg” fef women I’ve dated,” Gaetz gr grgrg

nerous as a partner. I think someone is trying to make that look criminal when it is not.rgrregrg” fef women I’ve dated,” Gaetz gr grgrg

- nerous as a partner. I think someone is trying to make that look criminal when it is not.rgrregrg” fef women I’ve dated,” Gaetz gr grgrg


You then need to clean out the registry of your computer

You then need to clean out the registry of your computer

- libXML2.dll is a file thats used by Windows to help process the various "XML" (Extensible Markup Language) settings & features of your system.


Coronavirus: How the common cold can boot out Covid

Coronavirus: How the common cold can boot out Covid

- The virus that causes the cold can effectively boot the Covid virus out of the bodys cells, say researchers Some viruses are known to compete.